Skip to main content

Table 1 Baseline characteristics

From: Access site complications after transfemoral aortic valve implantation - a comparison of Manta and ProGlide

  ProGlide Manta p
Number of patients 76 75  
Age (years) mean ± SD 80.8 ± 8.3 81.2 ± 6.5 0.728
Female, n (%) 46 (60.5) 33 (44.0) 0.042
BMI (kg/m2) 25.6 ± 4.7 25.7 ± 4.3 0.900
Diabetes, n (%) 14 (18.4) 15 (20.0) 0.805
Hypertension, n (%) 53 (69.7) 54 (72.0) 0.760
Prior PCI, n (%) 23 (30.3) 26 (34.7) 0.818
Prior CABG, n (%) 10 (13.2) 7 (9.3) 0.457
Kreatinin (μmol/L) 97.0 ± 33.9 97.3 ± 27.6 0.947
eGFR (CKD-EPI, mL/min/1.73 m2) 58.2 ± 19.7 59.8 ± 17.4 0.604
STS/ACC TAVR score (mean ± SD) 2.9 ± 1.0 2.8 ± 1.0 0.546
Echocardiographic parameters:
 LVEF (%) mean ± SD 54.2 ± 6.5 52.0 ± 11.2 0.138
 Mean aortic valve gradient (mmHg) mean ± SD 53.7 ± 15.6 51.4 ± 15.5 0.370
 Aortic valve area (cm2) mean ± SD 0.7 ± 0.2 0.6 ± 0.2 0.403
Anatomic data, minimal luminal diameter:
 Common femoral artery (mm) mean ± SD 7.8 ± 1.4 8.1 ± 1.5 0.247
 External iliac artery (mm) mean ± SD 8.2 ± 1.3 8.1 ± 1.4 0.815
 Calcification ≥ moderate, n (%) 48 (63.2) 32 (42.7) 0.012
  1. SD Standard Deviation, BMI Body Mass Index, PCI Percutaneous Coronary Intervention, CABG Coronary Artery Bypass Graft, eGFR estimated Glomerular Filtration Rate, STS/ACC Society of Thoracic Surgeons/American College of Cardiology, TAVR Transcatheter Aortic Valve Replacement LVEF Left Ventricular Ejection Fraction